A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors
Clinical trial NCT01954043 · COMPLETED
Trial details
- NCT number
- NCT01954043
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-20
- Primary completion
- 2016-02-29
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.